Curemark
PrivateLast Round
Early Funding
Mar 27, 2023
Total Funding Raised
$80.59M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Curemark is a biopharmaceutical company developing novel therapies for the treatment of serious unmet needs in neuro-developmental and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curemark Comparables
Compare Curemark with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yamo Pharmaceuticals | 83% | |
| Confluence Pharmaceuticals | 81% | |
| PaxMedica, Inc. | 79% |
Curemark Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 27, 2023 | ||||
| Private Placement | Jun 2, 2021 | ||||
| Early Funding | Sep 11, 2019 | ||||
| Private Placement | Feb 20, 2018 | ||||
| VC Round | Mar 20, 2017 | ||||
Private Equity | Jul 13, 2015 |
Curemark Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deutsch Capital | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 99% MoM, reaching 3.1K.
- Jun 2, 2021
$5M raised in a private placement round.
Curemark Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curemark's valuation, stock price, and market status.
Is Curemark a public or private company?
Curemark is a private company.
What is the current stock price of Curemark?
Curemark is a private company with no public stock price. No recent secondary market data is available.
How much is Curemark worth (valuation)?
Valuation information for Curemark is not publicly available.
Can I buy Curemark stock?
Curemark shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Curemark's last funding round?
Curemark's most recent funding round was VC Round on July 13, 2015.
Who are the main investors in Curemark?
Investor information for Curemark is not publicly disclosed.
Will Curemark IPO soon?
No public IPO plans have been announced for Curemark.
How can I track Curemark secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curemark's secondary market activity and sign up for updates.